S. Rist

Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome

Jacques‐Eric Gottenberg, Philippe Ravaud, Xavier Puéchal et al. · JAMA · 2014 · 300 citations

Medicine, Internal Medicine, Pharmacotherapy +16

Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

Jacques‐Eric Gottenberg, G. Cinquetti, C. Larroche et al. · Annals of the Rheumatic Diseases · 2012 · 222 citations

Life Sciences, Immunology, Internal Medicine +13

Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug

Jacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger et al. · JAMA · 2016 · 189 citations · Full text

Medicine, Immunology, Pharmacotherapy +15

Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS Cohort

Jacques‐Eric Gottenberg, Raphaèle Séror, Corinne Miceli‐Richard et al. · PLoS ONE · 2013 · 181 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey

Raphaèle Séror, Christophe Richez, Christelle Sordet et al. · Lara D. Veeken · 2013 · 143 citations

Medicine, Immunology, Neurology +13